Scott, Stuart A <br/><br/>
Copy number variation and warfarin dosing: evaluation of CYP2C9, VKORC1, CYP4F2, GGCX and CALU.  [electronic resource] 

 -  Pharmacogenomics  Feb 2012 
 - 297-307 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural 
<br/><br/><label>ISSN: </label>1744-8042 
<br/><br/><label>Standard No.: </label>10.2217/pgs.11.156  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Anticoagulants--therapeutic use<br/>Aryl Hydrocarbon Hydroxylases--genetics<br/>Calcium-Binding Proteins--genetics<br/>Carbon-Carbon Ligases--genetics<br/>Cohort Studies<br/>Cytochrome P-450 CYP2C9<br/>Cytochrome P-450 Enzyme System--genetics<br/>Cytochrome P450 Family 4<br/>DNA Copy Number Variations--drug effects<br/>Dose-Response Relationship, Drug<br/>Ethnicity--genetics<br/>Exons<br/>Female<br/>Gene Deletion<br/>Gene Duplication<br/>Humans<br/>INDEL Mutation<br/>Male<br/>Mixed Function Oxygenases--genetics<br/>Vitamin K Epoxide Reductases<br/>Warfarin--therapeutic use